To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.

3.0.0 4242 2024-07-24T15:21:19Z 2024-07-24T15:21:19Z House H HR 2023-06-21 118 [Congressional Record Volume 169, Number 108 (Wednesday, June 21, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CRENSHAW:H.R. 4242.Congress has the power to enact this legislation pursuantto the following:Section 8 of article 1 of the Constitution.The single subject of this legislation is:To direct the Secretary of Health and Human Services,acting through the Commissioner of Food and Drugs, to issueguidance on considerations for conducting clinical trials forpsychedelic assisted therapy[Page H3072]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2023-06-23T18:17:34Z Referred to 2023-06-21T14:01:35Z 2023-06-23 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2023-06-21 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2023-06-21 Introduced in House IntroReferral Intro-H 9 Library of Congress 2023-06-21 Introduced in House IntroReferral 1000 9 Library of Congress C001120 Rep. Crenshaw, Dan [R-TX-2] Dan Crenshaw R TX 2 N M001215 Rep. Miller-Meeks, Mariannette [R-IA-1] Mariannette Miller-Meeks R IA 1 2023-06-21 True K000389 Rep. Khanna, Ro [D-CA-17] Ro Khanna D CA 17 2023-06-21 True Health Administrative law and regulatory procedures 2024-02-12T21:00:33Z Alternative treatments 2024-02-12T21:00:33Z Department of Health and Human Services 2024-02-12T21:00:33Z Drug therapy 2024-02-12T21:00:33Z Drug, alcohol, tobacco use 2024-02-12T21:00:33Z Medical research 2024-02-12T21:00:33Z Health 2023-08-01T21:15:21Z

00 2023-06-21 Introduced in House 2024-07-19T19:39:44Z This bill requires the Food and Drug Administration (FDA) to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy, including how to request support from the FDA for related investigational use exemptions.

]]>

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy. Display Title 45 To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy. 2024-07-24T15:21:19Z Official Title as Introduced 6 To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy. 2024-03-18T21:02:47Z Introduced in House IH Introduced in House 2023-06-21T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr4242ih/xml/BILLS-118hr4242ih.xml 2023-06-23 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.